Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Cancer Control. 2020 Jan-Dec;27(1):1073274820964146. doi: 10.1177/1073274820964146.
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide. Survival rates are among the most important factors in quality control and assessment of treatment protocols. This study was aimed to assess the survival rate of colorectal cancer in Eastern Mediterranean Region Countries. In the present study we comprehensively searched 6 international databases including PubMed/Medline, ProQuest, Scopus, Embase, Web of Knowledge and Google Scholar for published articles until November 2018. The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was applied to evaluate the quality of included studies. The heterogeneity of papers was assessed with the Cochran Test and I-Square statistics. Meta-regression test was performed based on publication year, sample size and Human Development Index (HDI) of each study. Among the total of 1023 titles found in the systematic search, 43 studies were eligible to be included in the present meta-analysis. According to the results, the 1-year, 3-year and 5-year survival rate of patients with Colorectal Cancer was 88.07% (95% CI, 83.22-92.92), 70.67% (95% CI, 66.40-74.93) and, 57.26% (95% CI, 50.43-64.10); respectively. Furthermore, Meta-regressions did not show significant correlations between survival rate and year, sample size or Human Development Index. Survival rates, especially the 5-year survival rate in the EMRO were less than European countries and the USA. Documented and comprehensive evidence-based findings of the present meta-analysis can be used to enhance policies and outcomes of different medical areas including prophylaxis, treatment and health related objectives in colorectal cancer.
结直肠癌(CRC)是全球癌症相关死亡的第二大主要原因。生存率是质量控制和评估治疗方案的最重要因素之一。本研究旨在评估中东地中海地区国家结直肠癌的生存率。在本研究中,我们全面检索了 6 个国际数据库,包括 PubMed/Medline、ProQuest、Scopus、Embase、Web of Knowledge 和 Google Scholar,以获取截至 2018 年 11 月发表的文章。采用纽卡斯尔-渥太华队列研究质量评估表评估纳入研究的质量。使用 Cochran 检验和 I-Square 统计量评估论文的异质性。根据每项研究的发表年份、样本量和人类发展指数(HDI)进行元回归检验。在系统搜索中总共发现了 1023 个标题,其中 43 项研究符合纳入本荟萃分析的条件。根据结果,结直肠癌患者的 1 年、3 年和 5 年生存率分别为 88.07%(95%CI,83.22-92.92)、70.67%(95%CI,66.40-74.93)和 57.26%(95%CI,50.43-64.10)。此外,元回归分析未显示生存率与年份、样本量或人类发展指数之间存在显著相关性。生存率,尤其是 EMRO 地区的 5 年生存率,低于欧洲国家和美国。本荟萃分析的有文件记载和基于证据的结果可用于加强包括预防、治疗和与结直肠癌相关的健康目标在内的不同医学领域的政策和结果。